Loading chat...

ID H0339

Bill

Status

Passed

3/7/2018

Primary Sponsor

Health and Welfare Committee

Click for details

Origin

House of Representatives

2018 Regular Session

AI Summary

  • Allows licensed prescribers to authorize pharmacists to substitute a drug with another drug in the same therapeutic class if the prescriber indicates "therapeutic substitution allowed" or similar designation

  • Requires drug product substitution to be intended for formulary compliance with the patient's health insurance plan or to lower patient costs while maintaining safety

  • Requires patient opt-in and clear notification of differences between drug products, with the patient's right to refuse the substitution

  • Requires modification of prescriber's directions to allow equivalent drug amounts and notification to the original prescriber within five (5) business days of dispensing

  • Excludes biological products and narrow therapeutic index drugs from the substitution provisions

Legislative Description

Adds to existing law to establish provisions regarding certain drug product substitutions.

PHARMACY

Last Action

Reported Signed by Governor on March 7, 2018 Session Law Chapter 35 Effective: 07/01/2018

3/7/2018

Committee Referrals

Health and Welfare2/1/2018
Health and Welfare1/17/2018

Full Bill Text

No bill text available